Pulmonary arterial hypertension: advances in pathophysiology and management.

Indian Journal of Pharmacology
Sandeep ChopraDavis Cherian

Abstract

Pulmonary arterial hypertension (PAH) is a heterogeneous, hemodynamic, and pathophysiological state which is commonly found throughout the world, but the disease burden is greater in India and in other developing countries. It is a disease characterized by vascular obstruction and vasoconstriction leading to progressive increase in pulmonary vascular resistance and right ventricular failure. PAH is a progressive disorder carrying a poor prognosis; however, dramatic progress has occurred in our knowledge of its pathogenesis and consequently, its treatment over the last two decades. In this article, we attempt to provide an overview of the etiology, pathophysiology, and current therapeutic modalities in the treatment of PAH. Patients suspected to have PAH should be submitted to a battery of investigations which help in establishing the diagnosis, identifying the etiology, guiding in treatment and informing the prognosis. All patients should be considered for standard therapy with oxygen, anticoagulation, and diuretics for right heart failure. Oral calcium channel blockers should be used in patients with a favorable response to acute vasodilator challenge. Disease targeted therapies include prostacyclines, endothelin receptor bloc...Continue Reading

References

Jul 9, 1992·The New England Journal of Medicine·B W ChristmanJ E Loyd
Jan 1, 1989·Clinical Cardiology·R BhatiaM L Bhatia
Sep 1, 1995·The American Journal of Medicine·P HervéL Drouet
Feb 1, 1996·The New England Journal of Medicine·R J BarstUNKNOWN Primary Pulmonary Hypertension Study Group
Sep 10, 1998·American Journal of Respiratory and Critical Care Medicine·K OkadaM D Botney
Aug 3, 1999·American Journal of Respiratory and Critical Care Medicine·N NagayaK Miyatake
Jul 14, 2001·Indian Journal of Pediatrics·S L ChadhaD K Shukla
Mar 19, 2002·American Journal of Respiratory and Critical Care Medicine·Gerald SimonneauUNKNOWN Treprostinil Study Group
Mar 30, 2002·Journal of the American College of Cardiology·Ronald J RaymondWalker Long
Jun 1, 2002·Science·Liliana Attisano, Jeffrey L Wrana
Aug 2, 2002·The New England Journal of Medicine·Horst OlschewskiUNKNOWN Aerosolized Iloprost Randomized Study Group
Sep 3, 2002·Journal of the American College of Cardiology·Olivier SitbonGérald Simonneau
Sep 17, 2002·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Marshall I HertzBerkeley M Keck
Feb 11, 2003·Chest·Paul L EnrightUNKNOWN Cardiovascular Health Study
May 10, 2003·Lancet·James R Runo, James E Loyd
Jun 25, 2003·Journal of the American College of Cardiology·Robyn J BarstUNKNOWN Beraprost Study Group
Jan 22, 2004·Circulation·Rohit BudhirajaPaul M Hassoun
Mar 16, 2004·News in Physiological Sciences : an International Journal of Physiology Produced Jointly by the International Union of Physiological Sciences and the American Physiological Society·Judd W Landsberg, Jason X-J Yuan
Jun 11, 2004·The New England Journal of Medicine·K Srinath Reddy
Jul 14, 2004·Chest·David B BadeschUNKNOWN American College of Chest Physicians
Oct 23, 2004·ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs·Michel KindoO H Frazier
Feb 3, 2005·The European Respiratory Journal·V V McLaughlinL J Rubin
May 18, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Seiichiro SakaoNorbert F Voelkel
Jun 3, 2005·The Journal of Clinical Investigation·M Sean McMurtryEvangelos D Michelakis
Sep 30, 2005·The New England Journal of Medicine·Hossein A GhofraniFriedrich Grimminger
Nov 18, 2005·The New England Journal of Medicine·Nazzareno GalièUNKNOWN Sildenafil Use in Pulmonary Arterial Hypertension (SUPER) Study Group
Apr 26, 2006·Circulation·Marius M HoeperLewis J Rubin
Jul 19, 2006·Annals of Internal Medicine·Karen C PattersonHarrison W Farber
Sep 5, 2006·Pediatrics·Michael D PuchalskiLloyd Y Tani
Jun 26, 2007·American Journal of Physiology. Lung Cellular and Molecular Physiology·R James WhiteMark B Taubman
Aug 19, 2007·The American Journal of Cardiology·Javier SanzSanjay Rajagopalan
Feb 28, 2008·Physiological Genomics·Liliana Moreno-VinascoJoe G N Garcia
Jul 16, 2008·Heart·R K Kumar, S Shrivastava
Oct 1, 2008·Circulation·Evangelos D MichelakisMarlene Rabinovitch

❮ Previous
Next ❯

Citations

Oct 25, 2016·Indian Heart Journal·S HarikrishnanR Krishna Kumar
Feb 27, 2013·The American Journal of Cardiology·Aaron B Waxman, Roham T Zamanian
Sep 11, 2012·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Sonata JodeleRanjit Chima
Jan 26, 2017·Drug Development and Industrial Pharmacy·Harini Chowdary VadlamudiTejeswari N
Apr 18, 2018·Clinical Hemorheology and Microcirculation·Xing-Zhen SunJia-Xin Li
Jul 24, 2020·Current Opinion in Pulmonary Medicine·Gerald J MaarmanBrian Allwood
Mar 21, 2015··Walter G. O'Dell, Walter G. O'Dell

❮ Previous
Next ❯

Methods Mentioned

BETA
pregnancy tests

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.